Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cellobiose. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 1/20 | 0.56 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.56 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.56 |
| ▸ | AMY2A | P04746 | 4/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | AMY1A | P0DUB6 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 4/20 | 0.46 |
| ▸ | MGAM | O43451 | 2/20 | 0.46 |
| ▸ | SI | P14410 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | TYR | P14679 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cellobiose SCHEMBL3787881 | 0.98 | LGALS8 (0.57) | LGALS8LGALS3LGALS4AMY2AMEN1 | |
| Cellobiose SCHEMBL3711713 | 0.98 | LGALS8 (0.57) | LGALS8LGALS3LGALS4AMY2AMEN1 | |
| Maltose SCHEMBL5957027 | 0.98 | LGALS8 (0.57) | LGALS8LGALS3LGALS4AMY2AMEN1 | |
| Cellobiose SCHEMBL3787879 | 0.98 | LGALS8 (0.57) | LGALS8LGALS3LGALS4AMY2AMEN1 | |
| Cellobiose SCHEMBL20484015 | 0.97 | LGALS8 (0.56) | LGALS8LGALS3LGALS4AMY2AMEN1 | |
| Cellobiose SCHEMBL20484013 | 0.97 | LGALS8 (0.56) | LGALS8LGALS3LGALS4AMY2AMEN1 | |
| Cellobiose SCHEMBL9401086 | 0.94 | LGALS8 (0.56) | LGALS8LGALS3LGALS4AMY2AMEN1 | |
| Cellobiose SCHEMBL24202679 | 0.94 | LGALS8 (0.61) | LGALS8LGALS3LGALS4AMY2AMEN1 | |
| Maltotriose SCHEMBL24202675 | 0.94 | LGALS8 (0.61) | LGALS8LGALS3LGALS4AMY2AMEN1 | |
| Cellobiose SCHEMBL23752618 | 0.94 | LGALS8 (0.61) | LGALS8LGALS3LGALS4AMY2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6110501-A | A TABLET THAT UTILIZES MICROCAPSULES WHEREIN AN ACTIVE SUBSTANCE FORMS THE CORE OF THE MICROCAPSULE AND OTHER CHEMICAL AGENTS(SEEDS) ARE DISPERSED THROUGHOUT THE MICROCAPSULE SHELL TO STRENGTHEN THE SHELL | VERION INC. (US) | 2000-08-29 | — | — | US | disclosed |